QSAR as a tool for the development of potent antiproliferative agents by inhibition of choline kinase

Current Computer-Aided Drug Design

Volumn 3, Issue 4, 2007, Pages 297-313

  Nunez M C ^a   Conejo Garcia A ^a   Sanchez Martin R M ^a   Gallo, M A ^a   Espinosa, A ^a   Campos, J M ^a  

^a Facultad de Farmacia   (Spain)

Author keywords

Antiproliferative agents; Choline kinase; Electrostatic effects; Frontier orbitals; Hammet constants; Lipophilicity; QSAR

Indexed keywords

CELL CULTURE; CELL DEATH; DRUG PRODUCTS; ENZYMES; LEAD COMPOUNDS;

ANTIPROLIFERATIVE AGENTS; CHEMOTHERAPEUTIC AGENTS; CHOLINE KINASE; ELECTROSTATIC EFFECT; FRONTIER ORBITALS; HAMMET CONSTANT; LIPOPHILICITY; MOLECULAR COMPONENTS; QSAR; SYNTHESISED;

BIOACTIVITY;

1,1' (1,2 ETHYLENEBISBENZYL) BIS (4 PYRIDINIUM)DIBROMIDE DERIVATIVE; 1,1' BIPHENYL 3,3' DIYLMETHYLENE BIS[4 (4 CHLORO N METHYLANILINO)PYRIDINIUM]DIBROMIDE; 1,1' BIPHENYL 4,4' DIYLMETHYLENE BIS[4 (4 CHLORO N METHYLANILINO)PYRIDINIUM]DIBROMIDE; ANTINEOPLASTIC AGENT; ANTIPROLIFERATIVE AGENT; BIS 4 ACETYLPYRIDINIUM DERIVATIVE; BIS 4 AMINOQUINOLINIUM DERIVATIVE; BIS 7 AMINO 8 METHYLQUINOLINIUM DERIVATIVE; BIS 7 CHLORO QUINOLINIUM DERIVATIVE; BISGEMDIOL DERIVATIVE; BISPYRIDINIUM DERIVATIVE; BISQUINOLINIUM DERIVATIVE; CHOLINE KINASE; DEQUALINIUM DERIVATIVE; HEMICHOLINIUM 3; PERHYDROZEPINE DERIVATIVE; PHOSPHOTRANSFERASE INHIBITOR; PIPERIDINE DERIVATIVE; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HT29; CELL TRANSFORMATION; COLON CANCER; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; IC 50; LIPOPHILICITY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN TARGETING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; SOLVATION;

EID: 37249073891     PISSN: 15734099     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340907782799354     Document Type: Review

References (58)

1. Kerr, D.J.; Workman, P. New Molecular Targets for Cancer Chemotherapy, CRC Press: Boca Raton, FL, 1994.
2. Lacal, J.C.; Muscat, J.; Aaronson, S.A. Nature, 1987, 330, 269.
3. Jiménez, B.; del Peso, L.; Montaner, S.; Esteve, P.; Lacal, J.C. J. Cell. Biochem., 1995, 57, 141.
4. Ratnam, S.; Kent, C. Arch. Biochem. Biophys., 1995, 323, 313.
5. Pelech, S.L.; Vance, D.E. Biochem. Biophys. Acta, 1984, 779, 217.
6. Abdellatif, M.; MacLellan, W.R.; Schneider, M.D. J. Biol. Chem., 1994, 269, 15423.
7. Barbacid, M. Eur. J. Clin. Invest., 1990, 20, 225.
8. Wiesmüller, L.; Wittinghofer, F. Cell. Signal., 1994, 6, 247.
9. Bhakoo, K.K.; Williams, S.R.; Florian, C.L. Land, H.; Noble, M.D. Cancer Res., 1996, 56, 4630.
10. Cuadrado, A.; Carnero, A.; Dolfi, F.; Jiménez, B.; Lacal, J.C. Oncogene, 1993, 8, 2959.
11. Hernández-Alcoceba, R.; Saniger, L.; Campos, J.; Núñez, M.C.; Khaless, F.; Gallo, M.A.; Espinosa, A.; Lacal, J.C. Oncogene, 1997, 15, 2289.
12. Cannon, J. G. Med Res. Rev., 1994, 14, 505.
13. Hernández-Alcoceba, R.; Fernández, F.; Lacal, J.C. Cancer Res., 1999, 3112.
14. Cid, H.M.B.; Traenkle, C.; Baumann, K.; Pick, R.; MiesKlomfass, E.; Kostenis, E.; Mohr, K.; Holzgrabe, U. J. Med. Chem., 2000, 43, 2155.
15. Slickers, P.; Hillebrand, M,; Kittler, L.; Lober, G.; Suhnel, J. Anti-Cancer Drug Des., 1998, 13, 463.
16. Hansch, C.; Leo, A. In Exploring QSAR. Fundamentals and Applications in Chemistry and Biology; ACA Professional Reference Books; American Chemical Society: Washington, DC, 1995.
17. Campos, J.; Núñez, M.C.; Rodríguez, V.; Gallo, M.A.; Espinosa, A. Bioorg. Med. Chem. Lett., 2000, 10, 767.
18. Gillies, R.J.; Didier, N.; Denton, M. Anal. Biochem., 1986, 159, 109.
19. Schnall, S., Macdonald, J.S. In Manual of Oncologic Therapeutics; Macdonald, J.S.; Haller, D.G.; Mayer, R.J., Eds.; J.B. Lippincott Co.: Philadelphia, 1995; pp. 170-184.
20. Munavalli, S.; Hsu, F.-L.; Szafraniec, L.L.; Beaudry, W.T.; Poziornek, E. J. Mign. Reson. Chem., 1987, 24, 560.
21. Charton, M. Prog. Phys. Org. Chem., 1981, 13, 119.
22. Nelson, G.L.; Levy, G.C.; Cargioli, J.D. J. Am. Chem. Soc., 1972, 94, 3089.
23. Rekker, R.F.; de Kort, H.M. Eur. J. Med. Chem., 1979, 14, 479.
24. Högberg, T.; Norinder, U. In A Textbook of Drug Design and Development; Krogsgaard-Larsen, P.; Liljefors, T.; Madsen, U., Eds.; Harwood Academic Publishers: Amsterdam, 1996; pp. 94-130.
25. Dearden, J.C.; James, K.C. In Introduction to the Principles of Drug Design and Action; Smith, H.J., Ed.; Harwood Academic Publishers: Amsterdam, 1998; pp. 167-207.
26. Campos, J. Núñez, M.C.; Rodríguez, V.; Entrena, A.; Hernández-Alcoceba, R.; Fernández, F.; Lacall, J.C.; Gallo, M.A.; Espinosa, A. Eur. J. Med Chem., 2001, 36, 215.
27. Karelson, M.; Lobanov, V.S.; Katritzky, A.R. Chem. Rev., 1996, 96, 1027.
28. Redl, G.; Cramer R-D. III; Berkoff C.E. Chem. Soc. Rev., 1974, 3, 273.
29. Lubkowski, L; Blazejoswski, J. J. Phys. Chem., 1991, 95, 2311.
30. Reynolds, W.F.; Gomes, A.; Maron, A.; MacIntyre, D.W.; Tanin, A. Can. J. Chem. 1983, 61, 2376.
31. Galanakis, D.; Calder, J.A.D.; Ganellin, C.R.; Owen, C.S.; Dunn, M. J. Med. Chem., 1995, 38, 3536.
32. Davies, R.H., Timms, D., in: Smith H.J. (Ed.), Introduction to the Principles of Drug Design and Action, Harwood Academic Publishers: Amsterdam, 1998; pp. 51-96.
33. Miller, N.E.; Wander, M.C.; Cave, R.J. J. Phys. Chem. A, 1999, 103, 1084.
34. Foresman, J.B.; Keith, T.A.; Wiberg, K.B.; Snoonian, J.; Frisch, M. J. J. Phys. Chem., 1996, 100, 16098.
35. GAUSSIAN-94; Revision C.2, Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Gill, P.M.W.; Johnson, B.G.; Robb, M.A.; Cheeseman, J.R.; Keith, T.; Petersson, G.A.; Montgomery, J.A.; Raghavachari, K.; Al-Laham, M.A.; Zakrzewski, V.G.; Ortiz, J.V.; Foresman, J.B.; Cioslowski, J.; Stefanov, B.B.; Nanayakkara, A.; Challacombe, M.; Peng, C.Y.; Ayala, P.Y.; Chen, W.; Wong, M.W.; Andres, J.L.; Replogle, E.S.; Gomperts, R.; Martin, R.L.; Fox, D.J.; Binkley, J.S.; Defrees, D.J.; Baker, J.; Stewart, J.P.; Head-Gordon, M.; Gonzalez, C.; Pople, J.A. Gaussian Inc., Pittsburgh, PA, 1995.
36. Chen I.-J.; MacKerell A.D. Jr. Theor. Chem. Ace., 1999, 103, 483.
37. Schulman, E.M.; Bonner, O.D.; Schulman, D.R.; Laskovics, F.M. J. Am. Chem. Soc., 1976, 98, 3793.
38. Primrose, W.U.; MacKenzie, N.E.; Mathouse, J.P.G.; Scott, A.I. Bioorg. Chem., 1985, 13, 335.
39. (a) Gum, W.F. Jr; Joullié, M.M. J. Org. Chem. 1967, 32, 53.
40. (b) Ewing, D.F. In Correlation Analysis in Chemistry; Chapman, N.B.; Shorter, J., Eds.; Plenum: New York and London, 1978; p 357.
41. Jaffé, H.H. J. Chem. Phys., 1952, 20, 1554.
42. Jaffé, H.H.; Doak, G.O. J. Am. Chem. Soc., 1955, 77, 4441.
43. Deady, L.W.; Willett, G.D. Org. Magn. Reson., 1974, 6, 53.
44. Munavalli, S.; Szafraniec, L.L.; Beaudry, W.; Poziomek, E.J. Magn. Reson. Chem., 1986, 24, 743.
45. Hansch, C.; Leo, A.; Taft, W. Chem. Rev., 1991, 91, 165.
46. Viswanadhan, V.N.; Ghose, A.K.; Revankar, G.R.; Robins, R.K. J. Chem. Inf. Comput. Sci., 1989, 29, 163.
47. PALLAS FRAME MODULE, a prediction tool of physicochemical parameters, is supplied by CompuDrug Chemistry, Ltd, PO Box 23196, Rochester, NY 14692, USA.
48. Popova, R.S.; Popov, A.F.; Litvinenko, L.M. Zh. Org. Khim., 1970, 6, 1049;
49. Popova, R.S.; Popov, A.F.; Litvinenko, L.M. Chem. Abst., 1970, 73, 34485j.
50. Sánchez-Martín, R.M.; Campos, J.M.; Conejo-García, A.; Cruz-López, O.; Báñez-Coronel, M.; Rodríguez-González, A.; Gallo, M.A.; Lacal, J.C.; Espinosa, A. J. Med. Chem., 2005, 48, 3363.
51. Conejo-García, A.; Báñez-Coronel, M.; Sánchez-Martín, R.M.; Rodríguez-González, A.; Ramos, A.; Ramírez de Molina, A.; Espinosa, A.; Gallo, M.A.; Campos, J.M.; Lacal, J.C. J. Med. Chem., 2004, 47, 5433.
52. Hansch, C.; Leo, A. Substituent constants for correlation analysis in chemistry and biology; John Wiley & Sons: New York, 1979.
53. Campos, JM.; Núñez, M.C.; Sánchez, R.M.; Gómez-Vidal, J.A.; Rodríguez-González, A.; Báñez, M.; Gallo, M.A.; Lacal, J.C.; Espinosa, A. Bioorg. Med. Chem., 2002, 10, 2215.
54. Kubinyi, H. QSAR: Hansch Analysis and Related Approaches. In Methods and Principles in Medicinal Chemistry; Mannhold, R., Krogsgaard-Larsen, P., Timmerman, H., Eds.; VCH: Weinheim, 1993; Vol. 1, pp. 40-41.
55. Blaney, J.M.; Hansch, C. Quantitative Drug Design (Ramsden, C.A., Ed.). In Comprehensive Medicinal Chemistry. The Rational Design, Mechanistic Study & Terapeutic Application of Chemical Compounds; Hansch, C., Sammes, P.G., Taylor, J.B., Eds.; Pergamon Press: Oxford, 1990; Vol. 4, pp. 459-496.
56. Hansch, C.; Blaney, J.M. Chemische Struktur und biologische Aktivität von Wirkstoffen. Methoden der Quantitativen Struckutr-Wirkung-Analyse; Seydel, J.K.; Schaper, K.-J., Eds.; Verlag Chemie: Weinheim, 1979; pp. 185-208.
57. Lacal, J.C.; Campos, J.M.; Gallo, M.A.; Espinosa, A. Consejo Superior de Investigaciones Científicas and Universidad de Granada. Eur. Pat. Appl. WO 2005/068429 A1 (Cl. C07D 213/74); Chem. Abstr., 2005, 143, 172774.
58. Malito, E.; Sekulic, N.; Too, W. C.S.; Konrad, M.; Lavie, A. J. Mol. Biol., 2006, 364, 136.